Hongfang Chen
-
- MicroRNA in disease regulation 3
- Leadership and Management top 10%
-
- Advanced biosensing and bioanalysis techniques 3
-
- Acute Ischemic Stroke Management 13
-
- Stroke Rehabilitation and Recovery 6
-
- Cerebrovascular and Carotid Artery Diseases 4
-
- Venous Thromboembolism Diagnosis and Management 4
-
- Health and Well-being Studies 3
-
- Intracerebral and Subarachnoid Hemorrhage Research 3
- Journals
- SHILAP Revista de lepidopterología (1 paper)Stroke (1 paper)Oncogene (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Hongfang Chen
55 papers receiving 602 citations
Peers
Comparison fields: 5 of 124
- Cancer Research 130
- Leadership and Management 9
- Research and Theory 6
- Genetics 49
- Molecular Biology 253
Countries citing papers authored by Hongfang Chen
This map shows the geographic impact of Hongfang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfang Chen more than expected).
Fields of papers citing papers by Hongfang Chen
This network shows the impact of papers produced by Hongfang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfang Chen. The network helps show where Hongfang Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongfang Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 20 | |
| 9 | 2022 | 7 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 13 | |
| 15 | 2020 | 34 | |
| 16 | 2020 | 32 | |
| 17 | 2019 | 19 | |
| 18 | 2016 | 77 | |
| 19 | 2014 | 15 | |
| 20 | Cross-talking between JAK/STAT3 and MAPK/ERK Signaling Transduction Pathways on Invasion and Metastasis of The Human Breast Cancer Cells | 2009 | 1 |
About Hongfang Chen
Hongfang Chen is a scholar working on Leadership and Management, Research and Theory and Internal Medicine, having authored 64 papers that have together received 606 indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (13 papers), Stroke Rehabilitation and Recovery (6 papers), Cerebrovascular and Carotid Artery Diseases (4 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Health and Well-being Studies (3 papers), Intracerebral and Subarachnoid Hemorrhage Research (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (130 citations), Leadership and Management (9 citations) and Research and Theory (6 citations). Hongfang Chen has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Kai Feng, Ran‐Ran Ma, Chun-Feng David Hou, Changqing Zhao, Peng Gao, Xu Chen, Ya‐Wen Wang, Xu Chen, Duan‐Bo Shi and Haiting Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Stroke and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.